![]() |
|
|
Vol. 288, Issue 3, 1101-1106, March 1999
Unit of Critical Care Medicine, Royal Brompton Hospital, Imperial
College School of Medicine, National Heart and Lung
Institute, London, England
Prostaglandin (PG) release in cells expressing constitutive
cyclooxygenase-1 is known to be regulated by liberation of arachidonic acid by phospholipase A2 followed by metabolism by
cyclooxygenase. However, the relative contribution of phospholipase
A2 to the release of PGs in cells expressing
cyclooxygenase-2 is not clear. We addressed this question by using
radioimmunoassay to measure PGE2 release by human cells
(A549) induced to express cyclooxygenase-2 (measured by Western blot
analysis) by interleukin-1
. Cells were either unstimulated or
stimulated with agents known to activate phospholipase A2
(bradykinin, Des-Arg10-kallidin, or the calcium ionophore
A23187) or treated with exogenous arachidonic acid. When cells were
treated to express cyclooxygenase-2, the levels of PGE2
released over 15 min were undetectable; however, in the same cells
stimulated with bradykinin, A23187, or arachidonic acid, large amounts
of prostanoid were produced. Using selective inhibitors/antagonists, we
found that the effects of bradykinin were mediated by
B2 receptor activation and that prostanoid release was due to cyclooxygenase-2, and not cyclooxygenase-1, activity. In
addition, we show that the release of PGE2 stimulated by
either bradykinin, A23187, or arachidonic acid was inhibited by the
phospholipase A2 inhibitor arachidonate trifluoromethyl
ketone. Hence, we have demonstrated that PGE2 is released
by two components: induction of cyclooxygenase-2 and supply of
substrate, probably via activation of phospholipase A2.
This is illustrated in A549 cells by a clear synergy between the
cytokine interleukin-1
and the kinin bradykinin.
This article has been cited by other articles:
![]() |
S. M. Saleh, T. S. Mann, T. Peters, R. J. Betts, and P. J. Henry Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pascual, E. M. Carr, M. C. Seeds, M. Guo, R. A. Panettieri Jr., S. P. Peters, and R. B. Penn Regulatory features of interleukin-1beta-mediated prostaglandin E2 synthesis in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L501 - L508. [Abstract] [Full Text] [PDF] |
||||
![]() |
F L M Ricciardolo, M C Timmers, J K Sont, G Folkerts, and P J Sterk Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma Thorax, October 1, 2003; 58(10): 840 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grewal, S. Ponnambalam, and J. H. Walker Association of cPLA2-{alpha} and COX-1 with the Golgi apparatus of A549 human lung epithelial cells J. Cell Sci., June 1, 2003; 116(11): 2303 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. BARNES Endogenous Inhibitory Mechanisms in Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181. [Full Text] [PDF] |
||||